Share Name Share Symbol Market Type Share ISIN Share Description
Sopheon LSE:SPE London Ordinary Share GB00BSZM1369 ORD 20P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 690.00p 43,255 14:00:18
Bid Price Offer Price High Price Low Price Open Price
680.00p 700.00p 700.00p 683.00p 685.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 23.2 3.0 59.1 11.7 69.03

Sopheon (SPE) Latest News

More Sopheon News
Sopheon Takeover Rumours

Sopheon (SPE) Share Charts

1 Year Sopheon Chart

1 Year Sopheon Chart

1 Month Sopheon Chart

1 Month Sopheon Chart

Intraday Sopheon Chart

Intraday Sopheon Chart

Sopheon (SPE) Discussions and Chat

Sopheon Forums and Chat

Date Time Title Posts
18/3/201812:46Your partner for innovation performance1,286
07/2/201716:05SOPHEAN COULD ROCKET - 15M CAP100
20/4/201519:36SOPHEON - WHAT GIVES?40
28/1/201509:43The time has come349
29/7/201410:19News From Sopheon Today92

Add a New Thread

Sopheon (SPE) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2018-03-19 17:08:48690.005003,450.00O
2018-03-19 16:24:32694.804312,994.59O
2018-03-19 16:20:45690.004342,994.60O
2018-03-19 15:37:24683.001501,024.50O
2018-03-19 15:24:17690.001961,352.40O
View all Sopheon trades in real-time

Sopheon (SPE) Top Chat Posts

Sopheon Daily Update: Sopheon is listed in the Software & Computer Services sector of the London Stock Exchange with ticker SPE. The last closing price for Sopheon was 690p.
Sopheon has a 4 week average price of 590p and a 12 week average price of 342.50p.
The 1 year high share price is 700p while the 1 year low share price is currently 322p.
There are currently 10,003,971 shares in issue and the average daily traded volume is 46,794 shares. The market capitalisation of Sopheon is £69,027,399.90.
kaka47: Wandisco is worth over£250 Million with similar turnover Where as SPE is only worth £50 Million, Share price should be close to 25 pounds if we apply same ratings as wandisco Imho massive re rating coming
chadders: Good news for me as the convertibles were acting as a brake on the share price. Future 8% interest saving paves the way for a decent dividend methinks.
runthejoules: Great Ideas Update in SHARES magazine: HALF YEAR RESULTS continue the solid organic progress at enterprise innovation management software specialist Sopheon (SPE:AIM). Another eight new licences were sold in the latter part of the six month period, taking the total to 28 versus 20 this time last year. Importantly, future revenue expectations are increasingly being de-risked with visibility on $20.3m of income for the full year to 31 December 2017. This is an improvement on the $17.5m when we first flagged this stock idea on 22 June at 330p, with $10.5m of that figure under recurring sales contracts. While the share price may not have moved much since our original article, nothing has changed in terms of the investment case. The shares currently trade on 14 times this year’s anticipated 24p per share of earnings, based on FinnCap forecasts. The broker has stuck to its 620p share price target, implying more than 80% upside on a 12 month view. SHARES SAYS: Keep buying the Shares. Have to say I wish they'd done their job properly and updated us to sell at 500p, but given it's low liquidity, low volume August and small cap £24.5m atm this may move the stock a bit higher. They've also tipped XAF... which I sold out of at breakeven last night (facepalm, should have waited to see what was in it)
janeann: not quite the share price reaction I expected.
chadders: I'm keen to find out whether or not SPE is having any success in its chosen new target markets, particularly the financial sector. If so it could be a game changer. Anyone out there in financials involved in Accolade? Meanwhile I think we are vulnerable to a take over at the current share price which is still cheap in my opinion. A bit baffled by the 30% drop to the 360's after the finals, but pleased it presented buying opportunities. I'm a holder, strictly no advice intended.
meganxmas: ok thanks I get it ... I think with these instruments the decision to convert or take money lies with the loan note holder so highly likely to be conversion. at a converted sharecapital the effective market cap should really be adjusted upwards to where it is stated today on most sites ... assuming no movement in share price. I would agree that hope the company progresses such that will become not so relevant.
cfro: The share price weakness since the last results has been puzzling. At this current price we are now talking of an historic per of around eight and that is let alone any forward looking PER which is almost certainly lower still. I guess we will have to wait for the next trading update to find out how things are going but if you want my opinion the more the share price languishes down at these levels, then the more exposed the company is to a takeover. We have talked about a potential takeover here for a fair while now but it is more likely to happen than ever before if the market doesnt rate the company properly.
samsj: Regarding takeover, see my question on stockopedia. Did anyone ask the company about the DevFactory buying in 2015 and Eswcapital. I'm sure it's been discussed before but would appreciate any info. Also, as I understand Barry Mence owns AT LEAST 1.5 million of 7.5 million shares and he and directors were buying quite aggressively? Why would they do anything that risked tanking the share price? If I u derstand correctly they have considerable skin in the game, hence the postponing of the loan stock?
runthejoules: Ah, me topslicing, that's what's moved the share price back up again, you're welcome! I'm going to post this here with a recommendation that you get a subscription to Stockopedia yourself - there's any number of great tips that I've completely failed to capitalise on. And if anyone complains about me pasting it here I'll take it down. Sopheon (LON:SPE) Share price: 380p (+13%) No. shares: 7.4m Market cap: £28m Trading Update Posting this in response to reader request. Great news here: "...a strong performance in the second half of 2016, driven by a large number of license orders in the final quarter, including substantial activity with major enterprise customers. In addition to the effect of the stronger sales performance, the profitability of the business was further enhanced by cost efficiencies over the course of the year, and to a lesser extent by foreign exchange gains linked to the sharp fall in Sterling. As a consequence, the Board expects that reported revenues for the year ended 31 December 2016 will be in line with current market expectations. The Board also expects that, even when excluding the impact of the positive foreign exchange effects, EBITDA will be ahead, and pre-tax profits significantly ahead, of current market expectations." So to be absolutely clear, the good news today is due to margins and not sales. I haven't actually looked at this company before (it's great to engage with other investors, because you can get exposed to a lot more interesting ideas!) Anyway, I see that these shares have "multi-bagged" over the past year, rising from 60p. It's a software business, specialising in "Enterprise Innovation Management". Checking their website, I get the following summary: "Sopheon integrated Enterprise Innovation Performance solutions support everything you need for the entire innovation, new product development (NPD), and innovation governance lifecycle." And on the Introductory page for investors: Sopheon (LSE:SPE) is an international provider of software and services for product life cycle management. Our Accolade® solution supports strategic roadmapping, idea development, product portfolio management and the creation, commercialization and replacement of products. So that's reasonably clear, although without trying some of their software for yourself, or talking to staff, the company will inevitably feel like a black box as an investment. When investing in software, a basic test is the strength of cash flow - does the company generate real earnings, or is it capitalising too many of its expenses? Doing a quick test, I see that SPE capitalised £900k of development costs in H1, and amortised £1 million of intangibles (so that £1 million can be added back to net income, to arrive at operating cash flow). That looks like a fair match, and H1 in the previous year was also a fair match. Checking the final results for 2015, I see a similar positive pattern in terms of the match-up between development costs capitalised and intangibles amortised. So on an initial glance, I'd have good confidence in the earnings here. It ha a huge StockRank of 98, and looks worthy of further investigation.
trinko: Five of AIM's post-Brexit stars revealed By Andrew Hore | Fri, 30th September 2016 - 14:15 Long tail of companies Many, though, have been around a lot longer. Software company Sopheon (SPE) joined AIM in 1996 and the share price is nowhere near the heights of the tech boom or even its level ten years ago, but it is more than eight times the level it was at the beginning of 2015. One thing that this list does show is that companies that may have been written off as failures in the past because of their poor performance can redeem themselves. That may come from perseverance, like Futura, or by finding different assets, like SolGold and Sound Energy. The long tail of very small companies on AIM is often criticised but some of these companies do get a second wind and find a way of recovering a substantial part, or all, of their previous share price decline. Trinko
Sopheon share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20180320 00:26:21